Meet the Partner: Tampere University
Tampere University is responsible for studying the use of electrical impedance plethysmography technology for detecting deep vein thrombosis in the […]
Project Overview
The ThrombUS+ project is focused on developing a novel wearable diagnostic device to aid in the early detection and diagnosis of deep vein thrombosis (DVT). The project integrates cutting-edge technologies, including ultrasound, artificial intelligence, light reflection rheography, plethysmography, serious games, and extended reality, to create a comprehensive and user-friendly monitoring system. ThrombUS+ aims to provide patients and healthcare professionals with real-time insights, enhancing DVT diagnosis and treatment.
The ThrombUS+ project is funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 101137227 (Horizon Innovation Action | HORIZON-HLTH-2023-TOOL-05-05) and is co-funded by the European Union.
42 months
Starting Date: 1 January 2024
Ending Date: 30 June 2027
18 partners from Greece, Lithuania, France, Germany, USA, Italy, Finland and Spain
9.5 M€ budget
co-funded by the Horizon Europe Programme
Wearable Continuous Point-of-Care Monitoring, Risk Estimation and Prevention for Deep Vein Thrombosis
News & Events
Meet the Partner: ComfTech
ComfTech is an innovative manufacturer of wearable monitoring systems based on smart garments. As part of the ThrombUS+ project, ComfTech […]
Meet the Partner: medis Medizinische Messtechnik GmbH
medis GmbH: Expert developers of medical impedance measurement and Light-Reflection-Rheography technology for DVT detection in the ThrombUS+ project. Discover how […]
Horizon Innovation Action | Agreement No. 101137227
HORIZON-HLTH-2023-TOOL-05-05
Co-funded by the European Union
S2E2 Certified